Our immunoprecipitation and immunofluorescence analysis support the notion that p38β interacts with SET in AML cells, and knockdown of p38β, but not p38α, decreases SET protein levels and enhances PP2A activity. The gene discussed is PTPA; the disease is acute myeloid leukemia.